BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND CDKN2A, CDK4I, 1029, ENSG00000147889, P42771, p14, CMM2, ARF, TP16, p16, MTS1, p19, p16INK4a, INK4a, CDKN2, p16INK4, p14ARF, MLM, INK4 AND Prognosis
217 results:

  • 1. Integrated analysis of transcriptome and genome variations in pediatric T cell acute lymphoblastic leukemia: data from north Indian tertiary care center.
    Singh M; Sharma P; Bhatia P; Trehan A; Thakur R; Sreedharanunni S
    BMC Cancer; 2024 Mar; 24(1):325. PubMed ID: 38459434
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. DNA Copy Number Alterations and Copy Neutral Loss of Heterozygosity in Adult Ph-Negative Acute B-Lymphoblastic Leukemia: Focus on the Genes Involved.
    Risinskaya N; Gladysheva M; Abdulpatakhov A; Chabaeva Y; Surimova V; Aleshina O; Yushkova A; Dubova O; Kapranov N; Galtseva I; Kulikov S; Obukhova T; Sudarikov A; Parovichnikova E
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139431
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Differential expression of BCL11b and cdkn2a in CD30-positive peripheral T cell lymphoma: Retrospective study.
    Wang Y; Zhang F; Gao N; Bu P; Cui W; Xi Y
    Medicine (Baltimore); 2023 Nov; 102(46):e35531. PubMed ID: 37986346
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Outcomes of patients with blastoid and pleomorphic variant mantle cell lymphoma.
    Gerson JN; Handorf E; Villa D; Gerrie AS; Chapani P; Li S; Medeiros LJ; Wang M; Cohen JB; Churnetski M; Hill BT; Sawalha Y; Hernandez-Ilizaliturri FJ; Kothari S; Vose JM; Bast M; Fenske T; Rao Gari SN; Maddocks KJ; Bond D; Bachanova V; Kolla B; Chavez J; Shah B; Lansigan F; Burns T; Donovan AM; Wagner-Johnston N; Messmer M; Mehta A; Anderson JK; Reddy N; Kovach AE; Landsburg DJ; Glenn M; Inwards DJ; Ristow K; Karmali R; Kaplan JB; Caimi PF; Rajguru S; Evens A; Klein A; Umyarova E; Pulluri B; Amengual JE; Lue JK; Diefenbach C; Fisher RI; Barta SK
    Blood Adv; 2023 Dec; 7(24):7393-7401. PubMed ID: 37874912
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. CDC6, a key replication licensing factor, is overexpressed and confers poor prognosis in diffuse large B-cell lymphoma.
    Shen M; Zhang Y; Tang L; Fu Q; Zhang J; Xu Y; Zeng H; Li Y
    BMC Cancer; 2023 Oct; 23(1):978. PubMed ID: 37833632
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Characteristics and therapeutic approaches for patients diagnosed with T-ALL/LBL exhibiting t(8;14)(q24;q11)/TCRA/D:MYC translocation.
    Zhang X; Wang T; Zhang Y; Wang F; Chen J; Ni J; Sun R; Wei Z; Zhang G; Li W; Li J; Lu P
    Leuk Lymphoma; 2023 Dec; 64(13):2133-2139. PubMed ID: 37674391
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Genes of Predisposition to Childhood Beta-Cell Acute Lymphoblastic Leukemia in the Kazakh Population.
    Svyatova G; Boranbayeva R; Berezina G; Manzhuova L; Murtazaliyeva A
    Asian Pac J Cancer Prev; 2023 Aug; 24(8):2653-2666. PubMed ID: 37642051
    [TBL] [Abstract] [Full Text] [Related]  

  • 8.
    Al-Zayan NR; Ashour MJ; Abuwarda HN; Sharif FA
    Pediatr Hematol Oncol; 2024; 41(2):103-113. PubMed ID: 37578068
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Integrated genetic analyses of immunodeficiency-associated Epstein-Barr virus- (EBV) positive primary CNS lymphomas.
    Kaulen LD; Denisova E; Hinz F; Hai L; Friedel D; Henegariu O; Hoffmann DC; Ito J; Kourtesakis A; Lehnert P; Doubrovinskaia S; Karschnia P; von Baumgarten L; Kessler T; Baehring JM; Brors B; Sahm F; Wick W
    Acta Neuropathol; 2023 Sep; 146(3):499-514. PubMed ID: 37495858
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Association of cdkn2a/B mutations, PD-1, and PD-L1 with the risk of acute lymphoblastic leukemia in children.
    Ruan Y; Xie L; Zou A
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10841-10850. PubMed ID: 37314514
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. PRMT5 supports multiple oncogenic pathways in mantle cell lymphoma.
    Sloan SL; Brown F; Long M; Weigel C; Koirala S; Chung JH; Pray B; Villagomez L; Hinterschied C; Sircar A; Helmig-Mason J; Prouty A; Brooks E; Youssef Y; Hanel W; Parekh S; Chan WK; Chen Z; Lapalombella R; Sehgal L; Vaddi K; Scherle P; Chen-Kiang S; Di Liberto M; Elemento O; Meydan C; Foox J; Butler D; Mason CE; Baiocchi RA; Alinari L
    Blood; 2023 Sep; 142(10):887-902. PubMed ID: 37267517
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. TP53 or cdkn2a/B covariation in ALK/RET/ROS1-rearranged NSCLC is associated with a high TMB, tumor immunosuppressive microenvironment and poor prognosis.
    Jiang B; Hu L; Dong D; Guo Z; Wei W; Wang C; Shao W; Ma T; Chen Y; Li Q; Hu W
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10041-10052. PubMed ID: 37261522
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Identification and validation of a cellular senescence-related lncRNA signature for prognostic prediction in patients with multiple myeloma.
    Zeng T; Jiang S; Wang Y; Sun G; Cao J; Hu D; Wang G; Liang X; Ding J; Du J
    Cell Cycle; 2023 Jun; 22(12):1434-1449. PubMed ID: 37227248
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Prognostic Role of cdkn2a Deletion and p53 Expression and Association With MIPIb in Mantle Cell lymphoma.
    Gaudio F; Dicataldo M; Di Giovanni F; Cazzato G; d'Amati A; Perrone T; Masciopinto P; Laddaga FE; Musto P; Maiorano E; Ingravallo G
    Clin Lymphoma Myeloma Leuk; 2023 Aug; 23(8):599-605. PubMed ID: 37147150
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Comprehensive FISH testing using FFPE tissue microarray of primary lymph node tissue identifies secondary cytogenetic abnormalities in Mantle Cell lymphoma.
    Webb F; Morey A; Mahler-Hinder C; Georgousopoulou E; Koo R; Pati N; Talaulikar D
    Cancer Genet; 2023 Jun; 274-275():75-83. PubMed ID: 37094546
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Noninvasive genomic profiling of somatic mutations in oral cavity cancers.
    Xi Y; Negrao MV; Akagi K; Xiao W; Jiang B; Warner SC; Dunn JD; Wang J; Symer DE; Gillison ML
    Oral Oncol; 2023 May; 140():106372. PubMed ID: 37004423
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The prognostic value of IKZF1
    Kicinski M; Arfeuille C; Grardel N; Bakkus M; Caye-Eude A; Plat G; Ferster A; Uyttebroeck A; De Moerloose B; Rohrlich P; Suciu S; Bertrand Y; Cavé H
    Pediatr Blood Cancer; 2023 Jun; 70(6):e30313. PubMed ID: 36971444
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Locally advanced choroidal melanoma with favorable molecular prognosis - case report.
    Bălăşoiu AT; Ştefănescu-Dima AŞ; Bălăşoiu M; Ciurea RN; Muraru A; Dan AO; Simionescu CE
    Rom J Morphol Embryol; 2022; 63(4):645-652. PubMed ID: 36808200
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Richter transformation in Chronic Lymphocytic Leukemia.
    Innocenti I; Benintende G; Tomasso A; Fresa A; Autore F; Larocca LM; Laurenti L
    Hematol Oncol; 2023 Aug; 41(3):293-300. PubMed ID: 36433773
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Molecular and clinical diversity in primary central nervous system lymphoma.
    Hernández-Verdin I; Kirasic E; Wienand K; Mokhtari K; Eimer S; Loiseau H; Rousseau A; Paillassa J; Ahle G; Lerintiu F; Uro-Coste E; Oberic L; Figarella-Branger D; Chinot O; Gauchotte G; Taillandier L; Marolleau JP; Polivka M; Adam C; Ursu R; Schmitt A; Barillot N; Nichelli L; Lozano-Sánchez F; Ibañez-Juliá MJ; Peyre M; Mathon B; Abada Y; Charlotte F; Davi F; Stewart C; de Reyniès A; Choquet S; Soussain C; Houillier C; Chapuy B; Hoang-Xuan K; Alentorn A
    Ann Oncol; 2023 Feb; 34(2):186-199. PubMed ID: 36402300
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 11.